These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 21645397)
1. SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation. Acun T; Oztas E; Yagci T; Yakicier MC BMC Cancer; 2011 Jun; 11():223. PubMed ID: 21645397 [TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. Chan DW; Lee JM; Chan PC; Ng IO Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387 [TBL] [Abstract][Full Text] [Related]
3. PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas. Acun T; Demir K; Oztas E; Arango D; Yakicier MC OMICS; 2015 Apr; 19(4):220-9. PubMed ID: 25831062 [TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma. Yang XX; Sun JZ; Li FX; Wu YS; Du HY; Zhu W; Li XH; Li M World J Gastroenterol; 2012 Jun; 18(21):2719-26. PubMed ID: 22690083 [TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Li Z; Zhang H; Yang J; Hao T; Li S Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295 [TBL] [Abstract][Full Text] [Related]
6. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. Tong JH; Ng DC; Chau SL; So KK; Leung PP; Lee TL; Lung RW; Chan MW; Chan AW; Lo KW; To KF BMC Cancer; 2010 Jun; 10():253. PubMed ID: 20525238 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366 [TBL] [Abstract][Full Text] [Related]
8. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Comijn J; Berx G; Vermassen P; Verschueren K; van Grunsven L; Bruyneel E; Mareel M; Huylebroeck D; van Roy F Mol Cell; 2001 Jun; 7(6):1267-78. PubMed ID: 11430829 [TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma. Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538 [TBL] [Abstract][Full Text] [Related]
10. Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma. Sun JZ; Yang XX; Li XH; Xu WW; Wang Y; Zhu W; Li M Dig Dis Sci; 2011 Oct; 56(10):3072-7. PubMed ID: 21448695 [TBL] [Abstract][Full Text] [Related]
11. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma. Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332 [TBL] [Abstract][Full Text] [Related]
12. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Miyoshi A; Kitajima Y; Sumi K; Sato K; Hagiwara A; Koga Y; Miyazaki K Br J Cancer; 2004 Mar; 90(6):1265-73. PubMed ID: 15026811 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU. Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168 [TBL] [Abstract][Full Text] [Related]
14. SIP1 is a downstream effector of GADD45G in senescence induction and growth inhibition of liver tumor cells. Xu G; Zhang L; Ma A; Qian Y; Ding Q; Liu Y; Wang B; Yang Z; Liu Y Oncotarget; 2015 Oct; 6(32):33636-47. PubMed ID: 26378039 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas. Jin J; You H; Yu B; Deng Y; Tang N; Yao G; Shu H; Yang S; Qin W Biochem Biophys Res Commun; 2009 Jan; 379(1):86-91. PubMed ID: 19100240 [TBL] [Abstract][Full Text] [Related]
16. Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure. Zhang C; Fan L; Fan T; Wu D; Gao L; Ling Y; Zhu J; Li R; Wei L Cell Biochem Biophys; 2013 Mar; 65(2):187-95. PubMed ID: 22907585 [TBL] [Abstract][Full Text] [Related]
17. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma. Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009 [TBL] [Abstract][Full Text] [Related]
19. The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. Zhou X; Popescu NC; Klein G; Imreh S Cancer Genet Cytogenet; 2007 Aug; 177(1):6-15. PubMed ID: 17693185 [TBL] [Abstract][Full Text] [Related]
20. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Qiu G; Lin Y; Zhang H; Wu D Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]